We are live on ! Find out more
TRDA icon

Entrada Therapeutics

38 hedge funds and large institutions have $302M invested in Entrada Therapeutics in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 5 increasing their positions, 15 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding in top 10

Funds holding in top 10: 34 (+1)

24% more capital invested

Capital invested by funds: $243M → $302M (+$59M)

3.82% less ownership

Funds ownership: 82.81%78.99% (-3.8%)

21% less funds holding

Funds holding: 4838 (-10)

53% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 17

67% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 15

Holders
38
Holders Change
-10
Holders Change %
-20.83%
% of All Funds
0.64%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.07%
New
8
Increased
5
Reduced
15
Closed
17
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Legal & General Group
51
Legal & General Group
United Kingdom
-$8K -848 Closed
AIP
52
Ameritas Investment Partners
Nebraska
-$7K -708 Closed
Nisa Investment Advisors
53
Nisa Investment Advisors
Missouri
-$7K -700 Closed
Royal Bank of Canada
54
Royal Bank of Canada
Ontario, Canada
-$6K -646 Closed
CS
55
Credit Suisse
Switzerland
+$46 +6 New